RFMN in Combination With 1927 nm Thulium Laser for Treating Photoaged Skin
1 other identifier
interventional
35
1 country
1
Brief Summary
The appearance of the aging skin is influenced by different factors including by the reduced elasticity and increased laxity of the skin, the decreasing volume as well as pigmentation disorders and dilated vascular markings. Currently, there are different methods available to treat the aging skin. Here, the combined treatment of radiofrequency micro needling (RFMN) and thulium laser has been commonly used in clinical practice. The aim of this clinical study is to investigate the efficacy, patient satisfaction, safety of RFMN and thulium laser treatment in patients with facial, age-related skin laxity, wrinkles, and pigmented lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2023
CompletedFirst Posted
Study publicly available on registry
September 8, 2023
CompletedStudy Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedMay 21, 2024
May 1, 2024
12 months
August 23, 2023
May 20, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Change in wrinkles
software-assisted evaluation of wrinkles (Vectra(R) Software, Canfield)
6 months after last treatment session
Change in volume
software-assisted evaluation of volume (Vectra(R) Software, Canfield)
6 months after last treatment session
Change in pigmentation
software-assisted evaluation of pigmentation (Vectra(R) Software, Canfield)
6 months after last treatment session
Secondary Outcomes (3)
Pain intensity
10 minutes after starting each treatment session, one treatment session takes 30-50 minutes
Adverse Events
before every treatment session, at every follow-up visit (3 and 6 months post-treatment)
Withdrawals due to AE
before every treatment session, at every follow-up visit (3 and 6 months post-treatment)
Study Arms (2)
RFMN+Thulium
ACTIVE COMPARATORRFMN
ACTIVE COMPARATORInterventions
1. session: radiofrequency microneedling + 1927 nm thulium laser 2. session: 1927 nm thulium laser monotherapy 3. session: 1927 nm thulium laser monotherapy
1 session: radiofrequency microneedling monotherapy
Eligibility Criteria
You may qualify if:
- Men and women from the age of 30 years
- good general condition, no relevant previous diseases
- Presence of wrinkles, dermatochalasis on the face, pigment spots, which are an indication for RFMN and thulium laser or comparable methods
- Cognitive ability and willingness to give consent (informed consent)
- Be willing and able to attend follow-up visits
You may not qualify if:
- Age \< 30 years
- Pregnancy or breastfeeding
- Excessive subcutaneous fatty tissue under the cheeks
- Significant scarring of the region to be treated
- open wounds or lesions of the region to be treated
- Severe or cystic facial acne
- Metallic implants in the face or neck region
- Mental illnesses (psychoses, body perception disorders)
- Use of isotretinoin or other retinoids, psychotropic drugs, coumarins or heparins in the last 2 weeks
- Fillers in the region to be treated \< 4 weeks prior and during the study period
- Resurfacing (fractional, ablative, nonablative) of the region of interest \< 2 months prior and during the study period
- Plastic aesthetic procedures or other surgical procedures \< 6 months prior and during the study period
- Tendency to have excessive scarring
- Lack of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Hamburg-Eppendorf
Hamburg, 20251, Germany
Related Publications (9)
Berneburg M, Plettenberg H, Krutmann J. Photoaging of human skin. Photodermatol Photoimmunol Photomed. 2000 Dec;16(6):239-44. doi: 10.1034/j.1600-0781.2000.160601.x.
PMID: 11132125BACKGROUNDel-Domyati M, el-Ammawi TS, Medhat W, Moawad O, Brennan D, Mahoney MG, Uitto J. Radiofrequency facial rejuvenation: evidence-based effect. J Am Acad Dermatol. 2011 Mar;64(3):524-35. doi: 10.1016/j.jaad.2010.06.045.
PMID: 21315951BACKGROUNDZelickson BD, Kist D, Bernstein E, Brown DB, Ksenzenko S, Burns J, Kilmer S, Mehregan D, Pope K. Histological and ultrastructural evaluation of the effects of a radiofrequency-based nonablative dermal remodeling device: a pilot study. Arch Dermatol. 2004 Feb;140(2):204-9. doi: 10.1001/archderm.140.2.204.
PMID: 14967794BACKGROUNDNguyen L, Blessmann M, Schneider SW, Herberger K. Radiofrequency Microneedling for Skin Tightening of the Lower Face, Jawline, and Neck Region. Dermatol Surg. 2022 Dec 1;48(12):1299-1305. doi: 10.1097/DSS.0000000000003607. Epub 2022 Sep 29.
PMID: 36449871BACKGROUNDWang JV, Christman MP, Feng H, Ferzli G, Jeon H, Geronemus RG. Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser. J Cosmet Dermatol. 2021 Jan;20(1):105-109. doi: 10.1111/jocd.13817. Epub 2020 Nov 11.
PMID: 33174686BACKGROUNDLu K, Cai S. Efficacy and safety comparison between 1927 nm thulium laser and 2940 nm Er:YAG laser in the treatment of facial atrophic acne scarring: a prospective, simultaneous spilt-face clinical trial. Lasers Med Sci. 2022 Apr;37(3):2025-2031. doi: 10.1007/s10103-021-03465-0. Epub 2021 Nov 26.
PMID: 34826022BACKGROUNDSerra M, Bohnert K, Sadick N. A randomized, single-blind, study evaluating a 755-nm picosecond pulsed Alexandrite laser vs. a non-ablative 1927-nm fractionated thulium laser for the treatment of facial photopigmentation and aging. J Cosmet Laser Ther. 2018 Oct;20(6):335-340. doi: 10.1080/14764172.2018.1493513. Epub 2018 Jul 18.
PMID: 30019970BACKGROUNDFriedman PM, Dover JS, Chapas A, Rahman Z, Ross EV, Kilmer SL, Roberts WE, Sodha P, Stimmel JB, Moncrief MBC, Waibel JS. 1,550 nm Erbium-Doped and 1,927 nm Thulium Nonablative Fractional Laser System: Best Practices and Treatment Setting Recommendations. Dermatol Surg. 2022 Feb 1;48(2):195-200. doi: 10.1097/DSS.0000000000003321.
PMID: 35050945BACKGROUNDNguyen L, Blessmann M, Schneider SW, Herberger K. Radiofrequency Microneedling With 1927 nm Thulium Laser Versus Radiofrequency Microneedling Monotherapy for Rejuvenation of Photoaged Skin. J Cosmet Dermatol. 2026 Jan;25(1):e70685. doi: 10.1111/jocd.70685.
PMID: 41566557DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
August 23, 2023
First Posted
September 8, 2023
Study Start
December 15, 2023
Primary Completion
December 1, 2024
Study Completion
March 1, 2025
Last Updated
May 21, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share